GSA CAPITAL PARTNERS LLP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$231
+108.1%
81,688
+262.5%
0.02%
+109.1%
Q1 2023$111
-100.0%
22,534
-81.3%
0.01%
-93.3%
Q2 2022$1,100,000
+619.0%
120,533
+859.4%
0.16%
+685.7%
Q1 2022$153,000
-51.0%
12,564
-26.3%
0.02%
-50.0%
Q3 2019$312,000
-4.6%
17,048
-56.5%
0.04%
+133.3%
Q3 2016$327,000
-6.0%
39,200
-30.0%
0.02%
-18.2%
Q1 2016$348,000
-77.3%
56,019
-38.5%
0.02%
-70.7%
Q4 2015$1,535,000
+52.7%
91,073
+29.5%
0.08%
+53.1%
Q3 2015$1,005,000
+848.1%
70,319
+563.4%
0.05%
+600.0%
Q4 2014$106,000
-36.1%
10,600
-46.5%
0.01%
-22.2%
Q3 2014$166,00019,8000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders